Hamilton College

ElleVet Sciences Announces Expansion of Executive Leadership Team

Retrieved on: 
Tuesday, March 19, 2024
Consumer, Certified Public Accountant, Health, Certification, Machine learning, Cannabinoid, Growth, Shadrin, Science, Husson University, CBD, MBA, CBDA, Hamilton College, Safety, Operation, Pet, Multimedia, Marketing, Management

SOUTH PORTLAND, Maine, March 19, 2024 /PRNewswire-PRWeb/ -- ElleVet Sciences, the first company to prove the safety and efficacy of its hemp-based CBD products for pets, announces the recent expansion of its executive leadership team with the promotion of Haley Israelson to Chief Financial Officer, and addition of Ryan Shadrin as Chief Commercial Officer.

Key Points: 
  • SOUTH PORTLAND, Maine, March 19, 2024 /PRNewswire-PRWeb/ -- ElleVet Sciences , the first company to prove the safety and efficacy of its hemp-based CBD products for pets, announces the recent expansion of its executive leadership team with the promotion of Haley Israelson to Chief Financial Officer, and addition of Ryan Shadrin as Chief Commercial Officer.
  • "My journey with ElleVet has been one of personal and professional growth, and I'm excited to continue driving innovation and creating significant value with the ElleVet team."
  • The expansion of the ElleVet leadership team is a key milestone in the company's strategic growth plan.
  • "We are excited to announce the promotion of Haley and the hiring of Ryan as we continue to grow ElleVet Sciences and explore the role of cannabinoids in animal health," said Christian Kjaer, CEO and Co Founder of ElleVet Sciences.

BNP Paribas Exane Grows Global Team with Five Senior US Analyst Appointments

Retrieved on: 
Wednesday, February 14, 2024
Banking, Asset Management, Professional Services, Finance, Cortex, Research, Haitong Securities, Wellington Management Company, Research fellow, UBS, University, Hamilton College, Health care, Musical composition, Mathematics, BNP Paribas, Software, MBA, CFA, LATAM, Analyst, JPMorgan Chase, Consumer, Société Générale, Jefferies, Partnership, University of Scranton, Household, London Business School, Accounting, Automation, University of York, Barclays, Institutional Investor, AllianceBernstein, Deutsche Bank, Brooklyn College, Internet of things, TMT, International finance, Canaccord Genuity, Rutgers University, Morgan Stanley, Credit Suisse, Partner (business rank), Drink, Credit, Security (finance)

Sam has been with BNP Paribas Exane for eight years, and previously based in London where he was the Sector Head for Telecom Research.

Key Points: 
  • Sam has been with BNP Paribas Exane for eight years, and previously based in London where he was the Sector Head for Telecom Research.
  • Prior to joining BNP Paribas Exane in 2015, he spent five years at Sanford Bernstein on the European telecom research team.
  • Today’s appointments deliver on this ambition and are also another step in building out our BNP Paribas Exane US Research.
  • In 2021 BNP Paribas acquired 100 percent of Exane following a successful 17-year partnership and in November 2022, BNP Paribas launched BNP Paribas Exane in the US.

Privia Health Appoints Edward C. Fargis as General Counsel

Retrieved on: 
Monday, January 29, 2024
Family, General counsel, Corporation, Hamilton College, Happiness, Law, Mehrotra, Executive, History, Physician, Growth, Management

ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today.

Key Points: 
  • ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today.
  • Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-term direction and growth.
  • Mr. Fargis succeeds Thomas Bartrum, who plans to depart after serving as Privia’s general counsel since 2015.
  • Prior to joining Zelis, Mr. Fargis served as General Counsel, Secretary and Chief Compliance Officer for Personal Touch Home Health, Inc. Mr. Fargis also held various executive and other senior leadership positions for Touchstone Health Partnership, Inc. from November 2009 to December 2016, including the roles of Chief Executive Officer, General Counsel, Secretary and Chief Compliance Officer.

AuraVax Therapeutics Appoints Two Healthcare Veterans to its Board of Directors

Retrieved on: 
Tuesday, November 28, 2023
P&G, IAVI, International Society, Licensure, Research, GM, Therapy, Medical Center, ALS, Sanofi Pasteur, American Academy, Merck, Vaccine, Merck & Co., Antibody, Growth, New business development, Knowledge, Bangladesh Technical Education Board, IGM, Hamilton College, Pharmaceutical industry, Sanofi, Biotechnology, Microbiology, Economics, Medication

HOUSTON, Nov. 28, 2023 /PRNewswire/ -- AuraVax Therapeutics, Inc., a biotechnology company developing novel immunotherapies to prevent and treat respiratory viruses, today announced that Thomas Finn and John Shiver have joined the company's board of directors. They will serve with Laurence Cooper who is the chair of AuraVax's board.

Key Points: 
  • They join AuraVax at an exciting time as our lead product, NanoSTING-001, advances to clinical testing.
  • Finn serves as a Board member of Cincinnati Children's Medical Center and is Chair of their Research Committee.
  • He also serves as a Board member for Eikonoklastes Therapeutics, a Biotech company developing gene therapy for amyotrophic lateral sclerosis.
  • Shiver also serves as a board member of Icosavax Inc and IAVI Boards of Directors.

Issy Perez Joins Boyden United States as Managing Partner, Dallas, and Global Practice Leader, Consumer & Retail

Retrieved on: 
Thursday, November 9, 2023
Hamilton College, Shoe, Innovation, CPG, Mathematics, Consumer, Ministry of Digital Development, Innovation and Aerospace Industry (Kazakhstan), Kraft Foods, Kellogg School of Management, Procter & Gamble, Growth, Marketing, Travel, Black+Decker, Management, Retail

Dallas, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Boyden , a premier global leadership and talent advisory firm, is delighted to welcome new Managing Partner Issy Perez , head of the Dallas office and leader of the firm’s global consumer & retail practice , effective immediately.

Key Points: 
  • Dallas, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Boyden , a premier global leadership and talent advisory firm, is delighted to welcome new Managing Partner Issy Perez , head of the Dallas office and leader of the firm’s global consumer & retail practice , effective immediately.
  • “The consumer and retail industries are at the nexus of change, with internal and external pressures redefining strategy, infrastructure, and talent,” Issy commented.
  • Issy has over 25 years of experience in the consumer industry and 10 years of experience in global executive search.
  • Issy was previously Managing Director, Consumer Practice at a top-10 global talent advisory firm.

Risk Strategies Appoints Drew Carnase as Chief Operating Officer, Commercial Lines

Retrieved on: 
Monday, October 23, 2023
Insurance, Small business, Hamilton College, History, Chubb, Advisory board, Commerce, Commercial Operating System, Intact Insurance Specialty Solutions, Senior, National Directorate of Security, Hopkinton, Growth, Risk management, Byrne, Construction, Management

BOSTON, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Risk Strategies , a leading national specialty insurance brokerage and risk management and consulting firm, today announced Drew Carnase has been appointed as Chief Operating Officer, Commercial Lines.

Key Points: 
  • BOSTON, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Risk Strategies , a leading national specialty insurance brokerage and risk management and consulting firm, today announced Drew Carnase has been appointed as Chief Operating Officer, Commercial Lines.
  • As Chief Operating Officer, Commercial Lines, Carnase will focus on scaling and optimizing Risk Strategies Commercial Lines Operations by advancing its specialty focus, enhancing strategic and operational efficiencies, integrating newly acquired companies, and elevating the services and solutions available to clients.
  • “As Risk Strategies continues to grow rapidly, we are strategically investing in our leadership structure, aligning with our business priorities and specialties,” said John Scroope, National Director of Retail Operations, Risk Strategies.
  • He joined Risk Strategies two years ago to lead the national build-out and launch of the company’s small business commercial business unit.

Fiera Capital Appoints Eric Roberts as Executive Director and Chief Executive Officer, Fiera USA

Retrieved on: 
Tuesday, October 24, 2023
United Kingdom, Hamilton College, United, Growth, Business administration, Marketing, Head, Consultant, Master of Business Administration, Suffolk University, Executive director, TSX, Bachelor of Arts in Organizational Psychology, Management

MONTREAL and BOSTON, Oct. 24, 2023 /PRNewswire/ - Fiera Capital Corporation (TSX: FSZ) ("Fiera Capital" or the "Company"), a leading independent asset management firm, today announced the appointment of Eric Roberts as Executive Director and Chief Executive Officer, Fiera USA, effective November 13, 2023.

Key Points: 
  • MONTREAL and BOSTON, Oct. 24, 2023 /PRNewswire/ - Fiera Capital Corporation (TSX: FSZ) ("Fiera Capital" or the "Company"), a leading independent asset management firm, today announced the appointment of Eric Roberts as Executive Director and Chief Executive Officer, Fiera USA, effective November 13, 2023.
  • Eric will directly lead the marketing and distribution teams across the United States and provide executive leadership for all employees in the region.
  • In May, the Company appointed Klaus Schuster to the role of Executive Director and CEO, Fiera EMEA (Europe, Middle East, and Africa) and Rob Petty, who has been with Fiera for over five years, was also appointed to the role of Executive Director and CEO, Fiera Asia.
  • The Company's search for a new Executive Director and CEO, Fiera Canada is well underway.

William Blair Continues Private Capital Advisory Expansion, Augments Leadership in Its Fund Placement and Advisory Practice

Retrieved on: 
Tuesday, September 26, 2023
Professional Services, Finance, Consulting, Asset Management, Banking, Personal Finance, GP, Head, Credit Suisse, Hamilton College, Financial sponsor, Trust, Lazard, LP, Financial services

Wallace and Williams join the firm in New York as managing directors and co-heads of Private Capital Advisory alongside Mike Custar , who joined William Blair in 2022 and leads the firm’s Secondary Advisory practice, including both GP- and LP-led secondary solutions.

Key Points: 
  • Wallace and Williams join the firm in New York as managing directors and co-heads of Private Capital Advisory alongside Mike Custar , who joined William Blair in 2022 and leads the firm’s Secondary Advisory practice, including both GP- and LP-led secondary solutions.
  • The addition of Wallace and Williams bolsters the firm’s fundraising capabilities, providing financial sponsors with a fully integrated, comprehensive Private Capital Advisory practice.
  • Before Credit Suisse, Wallace was at Lazard in the Private Capital Advisory Group, advising financial sponsors on primary, secondary, and direct transactions.
  • “William Blair is a world-class firm and the perfect platform to partner with in building a fully integrated private capital advisory business.”

Replimune Announces Appointment of Emily Hill as Chief Financial Officer

Retrieved on: 
Tuesday, September 19, 2023
Actavis, PTC Therapeutics, Senior, Fordham University, Partner, Biotechnology, PTC, MBA, Biomedical Research, Hamilton College, Summer Street (Boston), CFO, Warner Chilcott, Growth, Therapy, Financial management, Pharmaceutical industry, Management, Science, Genzyme, Finance, Pharmacology

WOBURN, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of oncolytic immunotherapies, today announced the appointment of Emily Hill as Chief Financial Officer.

Key Points: 
  • WOBURN, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of oncolytic immunotherapies, today announced the appointment of Emily Hill as Chief Financial Officer.
  • “Emily brings a wealth of financial planning and strategy experience to Replimune that will be impactful as we look to transition to a commercial stage company,” said Philip Astley-Sparke, CEO of Replimune.
  • “I'm looking forward to applying my expertise and experience to help Replimune continue its growth and make the transition from a clinical to commercial stage company.”
    Prior to joining Replimune, Emily held numerous positions at PTC Therapeutics where she headed up Investor Relations before becoming the Company’s Chief Financial Officer.
  • Emily was heavily involved in PTC’s evolution from a development stage company to a five product company generating revenues approaching $1billion.

Group14 Technologies Appoints Chemical Industry Leader Dr. Kim Ann Mink to its Board of Directors

Retrieved on: 
Thursday, September 14, 2023
Duke University, Most, Analytical chemistry, University, Ernst & Young Entrepreneur of the Year Award, Dow, Doctor of Philosophy, Businessperson, Turnkey asset management program, Ford, Human, Research and development, Hamilton College, Wharton School of the University of Pennsylvania, Air Liquide, Phosphate, Chemical industry, Connection, Rohm, Haas, Growth, Silicon, Research, Woman, Widener University Commonwealth Law School, General Motors, Management, Chemistry

WOODINVILLE, Wash., Sept. 14, 2023 /PRNewswire/ -- Group14 Technologies, the leading global manufacturer and supplier of advanced silicon battery technology, today announced the appointment of Dr. Kim Ann Mink to its board as its second independent director. Dr. Mink's leadership and expertise in the chemical industry will be a crucial asset to support Group14's growth as it scales its global manufacturing capacity in the US, Asia and Europe.

Key Points: 
  • After more than three decades in large multinational chemical companies, Dr. Mink brings a unique industry perspective to the board.
  • "Group14 has been successful in commercializing a proven, protected and scalable technology that addresses a real market need," Dr. Mink said.
  • "With unparalleled industry experience as a leader at some of the most successful global chemical companies, Kim Ann is a dynamic, energetic and highly sought-after advisor, which makes her the perfect addition to strengthen Group14's board," said Rick Luebbe, CEO and co-founder of Group14 Technologies.
  • "As we gear up for company growth, Kim Ann will be a critical voice on the Group14 board as we execute on our long-term vision for the electrification of everything."